Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00114894 · ClinicalTrials.gov registry record · Phase 3
Prevention of Jellyfish Stings
A Phase 3 study of Bites and Stings, sponsored by University of Minnesota.
- Completed
- Registry status
- Phase 3
- Development phase
- 12
- Enrollment target
- 1
- Study location
NCT00114894 is a Phase 3 study of Bites and Stings that has completed, run by University of Minnesota. The registered enrollment target is 12 participants. The trial reports 1 study location across 1 state.
The verdict
NCT00114894, a Phase 3 study of Bites and Stings, has completed, sponsored by University of Minnesota.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 12 participants
- Enrollment target
- 1
- Study location
Study Summary
Jellyfish stings are a common occurrence among ocean-goers worldwide with an estimated 150 million envenomations annually. Fatalities and hospitalizations occur annually, particularly in the Indo-Pacific regions. A new topical jellyfish sting inhibitor based on the mucous coating of the clown fish prevents 85% of jellyfish stings in laboratory settings. The field effectiveness is unknown. This is a field test to determine the real world effectiveness.
Conditions Studied
Interventions
- OTHER Placebo
- OTHER Safe Sea ™
Study Locations (1)
Florida
- Dry Tortugas National Park - Key West
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 12 participants |
| Start Date | 2004-04 |
| Est. Completion | 2006-02 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00114894
The ClinicalTrials.gov registry entry for NCT00114894 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 12 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Minnesota, which has 966 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Bites and Stings appearing as the primary indexed condition, and to 2 interventions - of which Placebo is the first listed.
NCT00114894 reports 1 study location spanning 1 distinct geographic area - top geographies include Florida.
Frequently Asked Questions
What is clinical trial NCT00114894 about?
NCT00114894 is a clinical study titled "Prevention of Jellyfish Stings". Jellyfish stings are a common occurrence among ocean-goers worldwide with an estimated 150 million envenomations annually. Fatalities and hospitalizations occur annually, particularly in the Indo-Pacific regions. A new topical jellyfish sting inhibitor based on the mucous coating of the clown fish p...
What is the current status of trial NCT00114894?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 12 participants. The study started on 2004-04. Estimated completion is 2006-02.
What conditions does trial NCT00114894 study?
This clinical trial studies the following conditions: Bites and Stings.
What interventions are being tested in trial NCT00114894?
The interventions under investigation include: Placebo (OTHER), Safe Sea ™ (OTHER).
Who is sponsoring clinical trial NCT00114894?
This trial is sponsored by University of Minnesota, which has 966 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00114894 being conducted?
This trial has 1 study location across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.